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Abstract
Bakground: Pseudomonas aeruginosa is a major nosocomial uropathogen. It can tolerate a wide variety of  physical conditions and 
many antibiotics by different resistance mechanisms.
Objectives: This study aimed to investigate the mechanisms of  antibiotics resistance in uropathogenic P. aeruginosa clinical iso-
lates.
Methods: Two hundred sixty six urine samples were collected from Zagazig University Hospitals, Zagazig, Egypt. P. aeruginosa 
isolates were identified using standard microbiological tests. The sensitivity to different antibiotics was determined by disc diffu-
sion method. Anti-microbial resistance mechanisms were investigated using phenotypic methods and confirmed by PCR.
Results: Fifty P. aeruginosa isolates were recovered. All isolates were MDR and were resistant to amoxicillin/clavulinic, sulpha-
methaxzole/trimethoprim, doxycycline and ceftazidime. Phenotypic detection of  resistance mechanisms revealed that all strains 
have efflux mechanism, outer membrane porins, and AmpC β-lactamase; none of  the strains showed ESBL activity and two 
of  the imipenem resistant strains showed MβL activity. PCR analysis showed that all strains have MexAB-R, OprD and AmpC 
genes, 42 strains had PSE gene, while VEB and VIM genes were not detected.
Conclusion: The resistance rates in P. aeruginosa were higher than global values; this resistance was attributed to several mecha-
nisms. This high resistance is alarming and necessitates applying strict antibiotic prescription policies.
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Introduction
Pseudomonas aeruginosa is one of  the most ecologically sig-
nificant species among the genus Pseudomonas. P. aerugino-
sa is of  extreme importance because of  the widespread 
distribution of  its strains in nature, its high intrinsic an-
ti-bacterial resistance and its virulence1.
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P. aeruginosa is an opportunistic, hospital-acquired patho-
gen that causes severe diseases in immuno-compromised 
individuals including urinary tract infection. Urinary tract 
infections (UTIs) are some of  the most frequent bacterial 
infections, affecting 150 million people annually world-
wide2. P. aeruginosa is the third most common pathogen 
associated with nosoomial catheter-associated UTIs3. De-
spite advances in anti-microbial therapy, the mortality and 
morbidity associated with P. aeruginosa induced UTIs re-
main significantly high4. One key reason for therapy fail-
ure is the increased level of  antibiotic resistance among 
clinical P. aeruginosa isolates5. Thus, the detection of  the 
underlying resistance mechanisms is critical for better 
management of  this problem.
Many antibiotic resistance mechanisms have been report-
ed in P. aeruginosa including: 1) Reduced expression or loss 
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of  OprD porin causing reduced antibiotic permeability6, 
2) Over-expression of  MexAB-OprM pump which in-
creases antibiotic efflux7, 3) Production of  β-lactams and 
aminoglycosides inactivating enzymes8, 4) Mutations of  
gyrases and topoisomerases which causes fluoroquino-
lone resistance9. These mehanisms in combination lead 
to multiple drug resistance10.
β-lactamases are hydrolytic enzymes that are responsible 
for the resistance to β-lactam antibiotics. β-lactamases 
have many types including extended spectrum β-lact-
amases (ESBLs), AmpC β-lactamases, carbenicillin hy-
drolysing β-lactamase, Pseudomonas specific enzyme (PSE)
and metallo-β-lactamases (MβLs)11-13. ESBLs are encoded 
by different genes in P. aeruginosa including VEB gene11. 
MβLs are encoded by different genes including VIM (Ve-
rona Integron-encoded Metallo-β-lactamase) and IMP14.
Bacterial efflux pumps are greatly involved in the intrin-
sic resistance of  Gram-negative bacteria. When overex-
pressed, efflux pumps can confer high resistance to pre-
viously effective antibiotics. Many efflux pumps transport 
a wide range of  unrelated drugs and are known as mul-
tidrug resistance (MDR) efflux pumps. Four antibiotic 
efflux systems have been reported in P. aeruginosa. Mex-
AB-OprM is the efflux system that is responsible for ex-
trusion of  β-lactams and quinolones15.
The outer membrane of  P. aeruginosa represents a signifi-
cant barrier that hinders the penetration of  antibiotics. 
β-lactams and quinolones can only cross the outer mem-
brane through the porin proteins. P. aeruginosa produces 
several porins such as OprD and OprF. Loss or dimin-
ished expression of  OprD are frequently related to mipe-
nem resistance  i16.
This study was performed to detect antibiotic resistance 
profile of  local P. aeruginosa isolated from urinary tract 
infections and to determine the underlying resistance 




Mueller Hinton broth, Mueller Hinton agar and antibiot-
ic discs were purchased from Oxoid (Hampshire, UK). 
Ethidium bromide was obtained from Merck, Hohen-
burnn, Germany. MyTaqTM master mix was the product 
of  Bioline Reagents Limited, UK, while Gene-Ruler 100 
bp DNA Ladder was purchased from Thermoscientific 
Inc, USA. Other chemicals were of  pharmaceutical grade.
Bacterial strains
A total of  266 urine samples were collected from patients 
with urinary tract infections admitted to Urology Depart-
ment, Zagazig University hospitals, Zagazig, Egypt. Only 
one sample was collected per patient. Samples were col-
lected from clean-catch midstream fresh urine in sterile 
plastic jars. Samples were immediately transported to the 
Microbiological laboratory at Faculty of  Pharmacy, Zag-
azig University, where they were immediately processed. 
P. aeruginosa identification was based on standard microbi-
ological technique including: Gram staining, colony mor-
phology, motility, pigment production, oxidase reaction, 
growth at 42 °C, gelatin liquefaction test and sugar utili-
zation tests17.
Anti-microbial susceptibility testing:                                                               
Anti-microbial susceptibility testing was performed on 
Mueller Hinton agar (MHA) plates by disc diffusion meth-
od and interpreted according to Clinical Laboratory Stan-
dards Institute guidelines (CLSI)18.The tested classes of  
antibiotics were penicillins, carbapenems, cephalosporins, 
β-lactam/β-lactamase inhibitor combination, aminogly-
cosides, tetracyclines, chloramphenicol, sulphonamides 
and fluoro-quinolones. The antibiotic discs included ami-
kacin (30 µg), gentamicin (10 µg), piperacillin/tazobact-
am (100/10 µg), imipenem (10 µg), ceftazidime (30 µg), 
cefoperazone (10 µg), cefotriaxone (30 µg), cefotaxime 
(30 µg), cefepime (30 µg), amoxicillin/clavulanic acid 2:1 
(30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), chloram-
phenicol (30 µg), doxycycline (30 µg), pipracillin (100 µg) 
and sulphamethoxazole /trimethoprim (1.25/23.75 µg).
Phenotypic detection of  resistance mechanisms:
Phenotypic detection of  MβL activity:
The imipenem-resistant P. aeruginosa isolates were inves-
tigated for MβL production by imipenem-Ethylene di-
amine tetra acetic acid combined disc test (IMP-EDTA 
CDT) as described previously by Yong et al.19 Briefly, 
overnight culture of  the test organism was prepared and 
its turbidity was adjusted to a 0.5 McFarland standard and 
surface inoculated on MHA plate (9 cm in diameter). Two 
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imipenem discs (10 μg) were placed at a distance of  4-5 
cm from each other on the plate, and amount of  10 μL 
of  0.5M EDTA solution was added to one of  them. The 
inhibition zones of  the imipenem and imipenem-EDTA 
discs were compared after 18 h of  incubation at 35 °C. 
Isolates were considered as MβL positive if  the zone di-
ameter of  imipenem-EDTA disc was larger by more than 
or equal to 7 mm.
Phenotypic detection of  AmpC β-lactamases pro-
duction:
AmpC β-lactamase production was phenotypically de-
tected on the isolates that were resistant to cefoxitin ac-
cording to Vanwynsberghe et al.20 Briefly, ceftazidime (30 
μg) and cefotaxime (30 μg) disks were each placed at a 
distance of  20 mm from cefoxitin (30 μg) disk on a 9 
cm-diameter MHA plate inoculated with the test P. aerugi-
nosa isolate. The production of  AmpC enzyme was con-
firmed when the zones of  inhibition produced by either 
of  the cephalosporins (ceftazidime or cefotaxime) when 
used in conjunction with cefoxitin were ≥5 mm larger 
than cephalosporins inhibition zone alone.
 
Phenotypic detection of  extended spectrum β-lact-
amases (ESBL) production:
A lawn culture of  the organisms was made on a 9 cm-di-
ameter MHA plate, as recommended by CLSI21. A disc 
which contained ceftazidime-clavulanate (30/10 µg) and 
ceftazidime discs (30 μg) were placed at distance of  20 
mm. After an overnight incubation at 37°C, an increase 
of  5 mm in zone of  inhibition of  the combination discs 
in comparison to the ceftazidime disc alone was consid-
ered to be ESBL producer.
Phenotypic detection of  efflux pumps by ethidium 
bromide cartwheel (EtBr-CW) method
The ability of  efflux pumps to expel ethidium bromide 
was assessed according to EtBr-CW method22. Trypticase 
Soya Agar (TSA) plates containing EtBr ranging from 0 to 
4 mg/L (these concentrations were determined according 
to the bacterial MICs of  EtBr) were freshly prepared on 
the same day of  the experiment and kept protected from 
light. Overnight cultures of  the tested bacterial isolates 
were prepared and adjusted to a 0.5 McFarland turbidi-
ty standard. The 9 cm-diameter TSA plates were divided 
into ten to twelve sectors forming a cartwheel pattern. 
The adjusted bacterial cultures were swabbed on the Et-
Br-TSA plates starting from the center of  the plate to 
the margin. After incubation of  the plates at 37 ºC for 16 
h, the plates were examined under UV transilluminator 
(Cole-parmer, Vemon Hills, USA), the minimum concen-
tration of  EtBr that produced fluorescence of  the bacte-
rial mass was recorded. The isolates were considered Et-
Br-CW-negative if  they showed emission of  fluorescence 
at 0.5–1 mg/L EtBr, EtBr-CW intermediate (emitting 
fluorescence at 2 mg/L) or EtBrCW-positive (emitting 
fluorescence only at 3-4 mg/L).
Phenotypic detection of  outer membrane permea-
bility (OMP)
Assessment of  MDR bacteria for OMP was performed 
by determination of  the minimum inhibitory concentra-
tion (MIC) values for selected antibiotics in the presence 
and absence of  EDTA (pH=7.2); a permeabilizer which 
chelates divalent cations that stabilize molecular interac-
tions in the OM causing disruption of  OMP. To avoid 
the effect of  EDTA on bacterial growth, it was used at 
a concentration of  ¼ MIC. A four-fold reduction in the 
antibiotic MIC or more in the presence of  EDTA indi-
cates OM reduced permeability activity.
The MICs of  antibiotics and EDTA were determined 
by broth micro-dilution according to CLSI guidelines23. 
Müller Hinton broth (MHB) was inoculated with colonies 
of  P. aeruginosa and broth was incubated with shaking at 
37°C until the turbidity became equivalent to 0.5 McFar-
land standard. Then the bacterial suspension was diluted 
1:100 in MHB medium. Two-fold serial dilutions of  each 
drug were prepared in 96 wells microtiter plates in a final 
volume of  100 µL per well. Each well was inoculated with 
100 µL of  the previously prepared bacterial suspension 
and incubated at 37°C for 18 -20 h. MIC was defined as 
the lowest concentration of  drug at which there was no 
visible growth of  the organism. The results were record-
ed and interpreted according to CLSI23.
Genotypic detection of  resistance mechanisms by 
PCR.
The gDNA was extracted by picking a colony from an 
agar plate using a sterile pipette tip and resuspending it 
into 20 μL of  distilled water. The mixture was vortexed 
for 10 s then incubated at 98 °C for 5 min. The lysate was 
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centrifuged and the resulting supernatant was collected, 
diluted with distilled water at a 1:3 dilution ratio, and sub-
jected to PCR analysis. Each PCR mixture contained 10 
µL of  MyTaqTM master mix; 1.5 µL of  forward prim-
er, 1.5 µL of  reverse primer, 2 µL of  gDNA template 
and nuclease free water to 20 µL. The primers used in 
this study are listed in Table 1. The PCR was performed 
in Biometra T-personal thermocycler (Goettingen, Ger-
many). The PCR products as well as Gene-Ruler 100 bp 
DNA Ladder were separated on 1% agarose gel, stained 
with 2 µL of  EtBr, and visualized by UV transilluminator 
and photographed.
Detection of  Mex-ABR genes was done according to 
Al-Grawi et al.24  The cycling conditions were initial heat-
ing at 94°C for 3 min, then 32 cycles of  94°C for 30 sec, 
57°C for 45 sec and 72°C for 1min and final extension at 
72°C for 7min. OprD gene detection was performed ac-
cording to Rodríguez-Martínez et al.25 and included heat-
ing at 94 °C for 2 min, then 29 cycles of  94 °C for 20 sec, 
51 °C for 30 sec and 70 °C for 30 sec and final extension 
at 70 °C for 7 min. AmpC gene detection was according 
to Fazeli et al.26 and included heating at 94 °C for 2 min, 
then 29 cycles of  94 °C for 20 sec, 52.3 °C for 30 sec and 
70 °C for 15 sec and final heating at 70 °C for 7 min. PSE 
gene detection was following Neyestanaki et al.27, heating 
at 94 °C for 2 min, then 29 cycles of  94 °C for 20 sec, 
48.8 °C for 30 sec and 70 °C for 45 sec and finally heating 
at 70°C for 7 min. VEB gene detection was according to 
Qing et al.28 and include heating at 94°C for 2 min, then 
30 cycles of  94 °C for 20 sec, 52.4 °C for 30 sec and 70 
°C for 45 sec and finally heating at 70 °C for 7 min. VIM 
gene detection included heating at 94 °C for 2 min, fol-
lowed by 29 cycles of  94 °C for 20 sec, 51 ºC for 30 sec 




Only 50 P. aeruginosa strains were recovered from the 266 
urine samples (18.7%). The resistance rates of  P. aerugi-
nosa isolates to the tested antibiotics were presented in 
Figure 1. 
All the isolates were resistant to amoxicillin/clavulanic, 
sulphamethoxazole/ trimethoprim, doxycycline, chlor-
amphenicol and ceftazidime. Resistance to cefotaxime 
was 92% and 74% for ceftriaxone and cefepime, respec-
tively. The isolates showed low resistance to amikacin 
(2%), gentamicin (6%), levofloxacin (6%), ciprofloxacin 
(8%) and imipenem (10%). All of  the P. aeruginosa isolates 
were multidrug resistant (MDR). The resistance pattern 
of  the P. aeruginosa isolates was shown in Table 2.
 
Figure 1. The antibiotic resistance of P. aeruginosa isolates. 
African Health Sciences Vol 18 Issue 1, March, 2018      14
Table 1. Primer sequence and amplicon size 









CTCGACCCGATCTACGTC                     
GTCTTCACCTCGACACCC 
GAACTACCCCGTGAATCC              
CACTGGTCGAGGAGATGC                  
TGTCGAAGTTTTTCATTGATAG           







Al-Grawi et al.24 
  
Al-Grawi et al. 24 
  






242 Rodríguez-Martínezet al.25 
AmpC-F 
AmpC-R 
GCTCCACCAACGGCTTCCTGAGGATGGCGTAGGC 124 Fazeli et al. 26 
PSE-F 
PSE-R 
AATGGCAATCAGCGCTTC    
GCGCGACTGTGATGTATA 










390 Poire et al. 29 
  
Table 2.  Antibiotic resistance pattern of the clinical P. aeruginosa isolates 
  
Antibiotic resistance pattern No of isolates 
CN, AK, LEV, CIP, IMP, TPZ, CEP, PRL, FEP, CRO, CTX, DO, 
CAZ, C, STX, AMC 
1   
LEV, CIP, IMP, TPZ, CEP, PRL, FEP, CRO, CTX, DO, CAZ, C, 
STX, AMC 
1   
LEV, CIP, IMP, TPZ, CN, CEP, FEP, CRO, CTX, DO, CAZ, C, 
STX, AMC 
1   
TPZ, CEP, PRL, FEP, CRO, CTX, DO, CAZ, C, STX, AMC 11   
TPZ, CN, CIP, FEP, CRO, CTX, DO, CAZ, C, STX, AMC 1   
TPZ, CEP, FEP, CRO, CTX, DO, CAZ, C, STX, AMC 3   
TPZ, PRL, FEP, CRO, CTX, DO, CAZ, C, STX, AMC 1   
IMP, FEP, CRO, CTX, DO, CAZ, C, STX, AMC 1   
FEP, CRO, CTX, DO, CAZ, C, STX, AMC 13   
CRO, CTX, DO, CAZ, C, STX, AMC 4   
IMP, CTX, DO, CAZ, C, STX, AMC 1   
FEP, CTX, DO, CAZ, C, STX, AMC 2   
CTX, DO, CAZ, C, STX, AMC 6   
FEP, DO, CAZ, C, STX, AMC 2   
DO, CAZ, C, STX, AMC 2   
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Phenotypic detection of  resistance mechanisms
The IMP-EDTA-CDT was performed for the 5 imipe-
nem resistant isolates and the results revealed that 2 of  
these isolates were MβL producer (Fig. 2 A). All the 50 
MDR P. aeruginosa  isolates were phenotypically confirmed 
to produce AmpC β-lactamase (Fig. 2 B). All the MDR 
isolates were subjected to qualitative assessment for ef-
flux pumps by EtBr-CW method, and all of  the tested 
isolates showed efflux pump activity (Fig. 2 C). None of  
the MDR P. aeruginosa isolates were ESBL producers (Fig. 
2 D). EDTA was used for phenotypic detection of  OMP; 
generally EDTA potentiated the effect of  different anti-
microbial agents as it reduced the tested antibiotics MICs 
as indicated in Table 3.
 
Figure 2. Phenotypic detection of resistance mechanisms. A, detection of MβL by IMP-
EDTA-CDT method, positive isolates showed ≥7 mm increase in zone of inhibition in 
presence of EDTA; B, detection of AmpC β- lactamase, positive isolates show that 
zones of inhibition produced by cephalosporins (CAZ or CXT) when used with cefoxitin 
(Fox) were 5 mm bigger than cephalosporins zone alone;  C, detection of efflux pumps 
by EtBr-CW method, all the isolates did not show emission of fluorescence; D, 
detection of ESBL using ceftazidime (CAZ), and ceftazidime- clavulininc (CZC) discs, 
none of the isolates showed positive results.  
Table 3. The MIC50  (µg/mL) of some antibiotics (without and with   EDTA) 
  
Antibiotic MIC50 MIC50  in presence of 
EDTA 
Amikacin 8 0.5 
levofloxacin 2 0.125 
cefotaxime 512 32 
ceftazidime 1024 64 
 
African Health Sciences Vol 18 Issue 1, March, 2018      16
Genotypic detection of  resistance genes
PCR was used to detect resistance genes. Multiplex PCR 
was used for amplification of  MexA-B-R genes encoding 
efflux pumps, all the MDR isolates gave a triple band at 
280, 411 and 503 bp matching the Mex-B-R-A genes (Fig. 
3 A).
For OprD gene encoding outer membrane porins, all of  
the MDR isolates gave a single band at 242 bp match-
ing OprD gene (Fig. 3 B). For amplification of  AmpC 
gene encoding AmpC β-lactamase, all the MDR isolates 
gave a single band at 124 bp matching the AmpC gene 
(Fig. 3 C). In case of  PSE gene, 42 of  the MDR isolates 
gave a single band at 698 bp matching the PSE gene (Fig. 
3 D). For VEB gene encoding ESBL enzyme and VIM 
gene encoding MβL, none of  the tested isolates gave the 
648 bp band matched to VEB gene or the 390 bp band 
matching VIB gene.
 
Figure 3. Gel electrophoresis of PCR products for detection of resistance genes genes 
in selected MDR isolates. A, detection of MexA-B-OprM genes, all the isolates gave 
triple bands of 280 bp, 411bp and 503bp representing MexB, MexR and MexA genes, 
respectively; B, detection of OprD gene, all isolates gave a single band at 242 bp; C, 
detection of AmpC gene, all the isolates gavea single band at 124 bp; D, detection of 
PSE gene, positive isolates gave a single band at 698 bp. 
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Discussion
MDR isolates represents a prominent health problem in 
Egypt due to several factors including misuse of  antibiot-
ics and biocides30. In the current study, 50 P. aeruginosa iso-
lates were recovered from urine samples, all the isolates 
were MDR (100%), this MDR rate was higher than rates 
reported previously in Egypt which ranged from 34% - 
56%31-33; this may reflect higher resistance rate in case of  
urinary tract infections. Other global studies showed even 
lower MDR rates; 5.9% in Canada34, 19% in Germany35, 
19.6 % in Malaysia36 and 20.7% in Nepal37. This MDR 
rate is alarming and necessities application of  strict anti-
biotic prescription policies in our country.
The resistance rates were low to amikacin (2%), gentami-
cin (6%), levofloxacin (6%), ciprofloxacin (8%) and imi-
penem (10%). Previous studies also reported that amika-
cin and imipenem were the most effective drugs against 
P. aeruginosa26,31. Higher resistance rates were reported for 
pipracillin (28%), cefoperazone (34%), piperacillin/tazo-
bactam (36%)  cefotriaxone (74%),  cefepime (74%), and 
cefotaxime (92%), while all the isolates were resistant to 
ceftazidime, chloramphenicol, doxycycline, amoxicillin/
clavulanic and sulphamethoxazole/ trimethoprim. Selec-
tion of  curative antibiotic should always depend on the 
results of  antimicrobial susceptibility testing to avoid 
therapy failure. Inappropriate therapy has been associated 
with increased mortality in P. aeruginosa infections38.
In the current study, phenotypic detection of  MβL pro-
duction reveled that only 2 of  the 5 imipenem resistant 
isolates (40%) were MβL-positive. A previous Egyptian 
study reported relatively similar results where 27% of  P. 
aeruginosa were MβL producers39. PCR analysis showed 
that VIM gene (encoding MβL) was not detected in any 
of  our isolates. High prevalence of  VIM gene (58-61%) 
was reported previously in P. aeruginosa40, Probably the 
MβL activity in our study is attributed to other MβL genes 
or another mechanism. Several mechanisms of  imipenem 
resistance have been reported previously including secre-
tion of  carbapenemases, increased expression of  efflux 
systems, and reduced porin expression41. The isolation of  
carbapenem resistant strains is alarming and requires re-
striction on prescription of  these valuable drugs
Phenotypic analysis showed that none of  our isolates was 
an ESBL producer, this was comparable to the low occur-
rence (7.4%) reported previously in Egypt40. While Lin et 
al.42 found that 29% of  his strains were ESBL produc-
ers. PCR was used for detection of  VEB gene encoding 
ESBLs, the gene was not detected in any of  the isolate 
which is compatible with our phenotypic results. Zafer et 
al.40 reported that 10.4% of  ESBL-producing P. aeruginosa 
isolates were positive for VEB gene.
All of  the tested isolates were AmpC β-lactamase pro-
ducer. Chika et al.43 found that 36% of  P. aeruginosa iso-
lates were AmpC producers. The presence of  AmpC 
-lactamase enzyme was confirmed by PCR, all of  the P. 
aeruginosa isolates harbored the AmpC gene. Similarly, 
Fazeli et al.26 found that all the P. aeruginosa isolates had 
AmpC gene.
The Pseudomonas specific enzyme (PSE) belong to Class 
A carbenicillin hydrolysing β-lactamases that confer re-
sistance to carbenicillin and pipracillin. The presence 
of  PSE gene was tested by PCR, 42 isolate (84%) were 
found to have the PSE gene, it is worth mentioning that 
the 8 PSE-negative isolates were susceptible to pipracil-
lin. Cho et al.44 reported lower rate where only two out of  
61 Pseudomonas isolates (3.3%) harbored PSE gene. The 
AmpC and PSE are the main hydrolyzing enzymes that 
confer β-lactam resistance in our study.
The efflux system contributes to the natural bacterial re-
sistance to a wide range of  antibiotics and detergents45, 
46. In our study, active efflux was detected in all isolates. 
This was in accordance with Rana et al.47 who reported 
presence of  active efflux in all MDR isolates. Presence of  
MexABR efflux system was confirmed by amplification 
of  this operon using multiplex PCR. All of  the P. aerugi-
nosa isolates were positive to the three tested genes. This 
was in accordance with Al-Grawi et al.24 who found that 
all of  the P. aeruginosa isolates were positive to the three 
genes.
Our study also investigated the outer membrane reduced 
permeability as a resistance mechanism; assay was per-
formed with EDTA as a permeabilizer. The MIC values 
for tested antibiotics was determined in the presence and 
absence of  sub MIC (1/4 MIC) of  EDTA. Our results 
showed that EDTA has augmenting effect on different 
anti-microbial agents; EDTA reduced the MICs of  var-
ious anti-microbials by up to 16 folds. This was compa-
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rable with the results of  Ayres et al.48 who reported that 
EDTA was greatly enhanced the activity of  various anti-
biotics and biocides against Gram negative isolates.
Conclusion
This study revealed that the resistance rates of  local P. 
aeruginosa were higher than worldwide values. This high 
resistance was attributed to several mechanisms including 
efflux pumps, reduced activity of  outer membrane po-
rins, production of  AmpC and PSE β-lactamases. This 
high MDR resistance rate is alarming which necessitates 
applying strict antibiotic usage and prescription policies. 
Also selection of  curative antibiotics should depend on 
the anti-microbial susceptibility results. 
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